glp 1 and hashimotos GLP-1 Receptor Agonists: A Promising Therapy for Modern Lifestyle Diseases with Unforeseen Challenges Microdosing GLP-1 for Hashimoto's: Evidence,

Comparative studies indicate semaglutide producing a 15.8 percent mean weight loss at 68 weeks versus 6.4 percent with liraglutide, emphasizing its strong and sustained impact on weight management

Patients have often been struggling with obesity for 5, 10, 15 years

Telogen Effluvium Associated With Weight Loss: A Single-Center Retrospective Study 7

Phentermine may have a role in specific scenariossuch as short-term use (typically 12 weeks or less) in patients with no cardiac historybut evidence increasingly favors GLP-1 monotherapy as a first-line approach due to better safety margins and sustained weight loss

Saxagliptin is much more potent, with a 5-fold greater inhibition of DPP-4 compared to vildagliptin [7], [17], [20]